Myeloid Cells & Neuroinflammation

Myeloid cells in the CNS are innate immune cells that are essential for brain development and maintenance. Here is the latest research on myeloid cells, including microglia, in neuroinflammation.

September 16, 2021

Gα13 Contributes to LPS-Induced Morphological Alterations and Affects Migration of Microglia.

Molecular Neurobiology
Barbara BettegazziDaniele Zacchetti
September 16, 2021
Open Access

Fas/FasL Contributes to HSV-1 Brain Infection and Neuroinflammation.

Frontiers in Immunology
Malgorzata KrzyzowskaKristina Eriksson
September 16, 2021

Neuroinflammatory Signaling in the Pathogenesis of Alzheimer's Disease.

Current Neuropharmacology
Md Sahab UddinGhulam Md Ashraf
September 16, 2021
Preprint
Open Access

Long-term in vivo imaging of mouse spinal cord through an optically cleared intervertebral window

BioRxiv : the Preprint Server for Biology
W. WuJianan Qu
September 16, 2021

Control of hippocampal pKr-2 expression reduces neurotoxic symptoms in 5XFAD mice.

British Journal of Pharmacology
Sehwan KimSang Ryong Kim
September 14, 2021

Oxymatrine inhibits neuroinflammation byRegulating M1/M2 polarization in N9 microglia through the TLR4/NF-κB pathway.

International Immunopharmacology
Xiao-Long WangXiao-Dong Peng
September 14, 2021
Review

Metabolic Regulation of Glia and Their Neuroinflammatory Role in Alzheimer's Disease.

Cellular and Molecular Neurobiology
Kumari PreetiValencia Fernandes
September 12, 2021
Review

Potentiation of microglial endocannabinoid signaling alleviates neuroinflammation in Alzheimer's disease.

Neuropeptides
Deepthi RapakaPaul C Adiukwu
September 10, 2021
Open Access

Traumatic Brain Injury Induces cGAS Activation and Type I Interferon Signaling in Aged Mice.

Frontiers in Immunology
James P BarrettDavid J Loane
September 10, 2021
Preprint
Open Access

Long-term persistence of viral RNA and inflammation in the CNS of macaques exposed to aerosolized Venezuelan equine encephalitis virus.

BioRxiv : the Preprint Server for Biology
H. MaDouglas S. Reed
September 10, 2021

Nitro-oleic acid-mediated blood-brain barrier protection reduces ischemic brain injury.

Experimental Neurology
Chao ZhouKe-Jie Yin
September 9, 2021

miR‑4792 regulates inflammatory responses in Cryptococcus neoformans‑infected microglia.

International Journal of Molecular Medicine
Guotai YaoJianghan Chen
September 9, 2021
Open Access

Siglec-H-Deficient Mice Show Enhanced Type I IFN Responses, but Do Not Develop Autoimmunity After Influenza or LCMV Infections.

Frontiers in Immunology
Nadine SzumilasLars Nitschke

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Acute Hemorrhagic Leukoencephalitis

Acute hemorrhagic leukoencephalitis is a rare form of acute disseminated encephalomyelitis characterized by acute inflammation in the brain and spinal cord that causes demyelination and bleeding. It is often fatal, although treatment with immunosuppressives and plasma exchange can be helpful. Find the latest research on acute hemorrhagic leukoencephalitis here.

© 2021 Meta ULC. All rights reserved
/feed-previews/myeloid-cells-neuroinflammation/91e171cf-d415-41ec-88e4-84b8abe3982e